Nifty

:

26172.40

Sensex

:

85567.48

206.00 (0.79%)
638.12 (0.75%)

Login

Nifty
Sensex

:
:

26172.40
85567.48

206.00 (0.79%)
638.12 (0.75%)

Solara Active Pharma Sciences Ltd.

Pharmaceuticals & Drugs - API

Rating :

51/99

BSE: 541540 | NSE: SOLARA

Watchlist

NSE BSE

572.95

22-Dec-2025

Open
High
Low
Previous Close

579.6
580
570.7
573.80

Volume
Traded Value (lacs)
52 Week High
52 Week Low

57672
33187007
734.4
442.8

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,758.79
430.39
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,378.27
N/A
2.19

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-4.51
-3.84

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-11.77
9.03

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-69.98
-63.50

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
2.00
1.79

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-0.87
-13.82

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 313.54 346.95 -9.63% 319.15 363.49 -12.20% 273.01 299.43 -8.82% 300.31 211.94 41.70%
Expenses 278.79 285.63 -2.39% 262.12 321.25 -18.41% 230.42 289.63 -20.44% 242.62 373.61 -35.06%
EBITDA 34.75 61.32 -43.33% 57.03 42.24 35.01% 42.59 9.80 334.59% 57.69 -161.67 -
EBIDTM 11.08% 17.67% 17.87% 11.62% 15.60% 3.27% 19.21% -76.28%
Other Income 0.49 0.32 53.12% 0.98 1.38 -28.99% 5.95 1.63 265.03% 1.49 0.44 238.64%
Interest 20.83 28.28 -26.34% 23.90 30.87 -22.58% 29.12 30.62 -4.90% 26.54 25.37 4.61%
Depreciation 24.49 25.34 -3.35% 23.58 25.07 -5.94% 24.30 25.10 -3.19% 24.54 25.96 -5.47%
PBT -10.08 8.02 - 10.53 -12.32 - -4.88 -167.61 - 8.10 -275.33 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 88.79 -100.00% 0.00 0.00 0
PAT -10.08 8.02 - 10.53 -12.32 - -4.88 -256.40 - 8.10 -275.33 -
PATM -3.21% 2.31% 3.30% -3.39% -1.79% -85.63% 2.70% -129.91%
EPS -2.09 1.66 - 2.18 -2.56 - -1.01 -53.20 - 1.68 -57.12 -

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 313.54 346.95 -9.63% 319.15 363.49 -12.20% 273.01 299.43 -8.82% 300.31 211.94 41.70%
Expenses 278.81 285.64 -2.39% 262.13 321.57 -18.48% 227.64 289.67 -21.41% 242.63 373.63 -35.06%
EBITDA 34.73 61.31 -43.35% 57.02 41.92 36.02% 45.37 9.76 364.86% 57.68 -161.69 -
EBIDTM 11.08% 17.67% 17.87% 11.53% 16.62% 3.26% 19.21% -76.29%
Other Income 0.49 0.32 53.12% 0.98 0.56 75.00% 5.95 1.70 250.00% 1.49 0.45 231.11%
Interest 20.83 28.28 -26.34% 23.90 30.87 -22.58% 29.12 30.69 -5.12% 26.54 25.37 4.61%
Depreciation 24.49 25.34 -3.35% 23.58 25.07 -5.94% 24.30 25.25 -3.76% 24.54 25.96 -5.47%
PBT -10.10 8.01 - 10.52 -13.46 - -2.10 -166.66 - 8.09 -275.34 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 88.79 -100.00% 0.00 0.00 0
PAT -10.10 8.01 - 10.52 -13.46 - -2.10 -255.45 - 8.09 -275.34 -
PATM -3.22% 2.31% 3.30% -3.70% -0.77% -85.31% 2.69% -129.91%
EPS -2.27 1.99 - 2.37 -3.35 - -0.52 -65.37 - 2.01 -70.49 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Net Sales 1,206.01 1,283.76 1,288.92 1,443.81 1,268.34 1,616.88 1,321.75 1,408.58 560.41 Net Sales Growth -1.29% -0.40% -10.73% 13.83% -21.56% 22.33% -6.16% 151.35% Cost Of Goods Sold 553.42 626.41 805.02 788.83 653.89 724.41 598.87 724.03 293.33 Gross Profit 652.59 657.35 483.90 654.98 614.45 892.47 722.88 684.55 267.08 GP Margin 54.11% 51.21% 37.54% 45.36% 48.45% 55.20% 54.69% 48.60% 47.66% Total Expenditure 1,013.95 1,079.92 1,383.98 1,309.77 1,187.99 1,231.55 1,065.22 1,196.30 499.02 Power & Fuel Cost - 94.37 122.56 107.95 93.70 85.42 77.68 79.35 31.41 % Of Sales - 7.35% 9.51% 7.48% 7.39% 5.28% 5.88% 5.63% 5.60% Employee Cost - 211.68 243.92 228.05 234.20 227.63 202.24 185.99 70.54 % Of Sales - 16.49% 18.92% 15.80% 18.47% 14.08% 15.30% 13.20% 12.59% Manufacturing Exp. - 68.51 109.99 91.64 100.57 95.82 94.74 101.85 48.02 % Of Sales - 5.34% 8.53% 6.35% 7.93% 5.93% 7.17% 7.23% 8.57% General & Admin Exp. - 37.99 40.94 39.21 49.55 48.16 50.96 35.72 14.78 % Of Sales - 2.96% 3.18% 2.72% 3.91% 2.98% 3.86% 2.54% 2.64% Selling & Distn. Exp. - 24.31 34.18 32.47 31.83 33.88 26.40 31.33 17.84 % Of Sales - 1.89% 2.65% 2.25% 2.51% 2.10% 2.00% 2.22% 3.18% Miscellaneous Exp. - 16.65 27.37 21.62 24.25 16.23 14.33 38.03 23.10 % Of Sales - 1.30% 2.12% 1.50% 1.91% 1.00% 1.08% 2.70% 4.12% EBITDA 192.06 203.84 -95.06 134.04 80.35 385.33 256.53 212.28 61.39 EBITDA Margin 15.93% 15.88% -7.38% 9.28% 6.34% 23.83% 19.41% 15.07% 10.95% Other Income 8.91 9.14 5.37 22.14 18.76 28.41 27.51 12.03 2.29 Interest 100.39 114.81 105.97 90.06 75.27 84.47 77.88 82.48 25.17 Depreciation 96.91 99.25 103.03 110.90 112.01 108.31 93.67 83.39 36.56 PBT 3.67 -1.08 -298.69 -44.78 -88.17 220.96 112.49 58.44 1.95 Tax 0.00 0.00 78.54 -22.57 -33.10 0.00 0.00 -0.23 0.00 Tax Rate 0.00% 0.00% -16.08% 50.40% 36.11% 0.00% 0.00% -0.39% 0.00% PAT 3.67 -1.08 -566.87 -22.21 -58.56 220.96 112.49 58.67 1.95 PAT before Minority Interest 3.67 -1.08 -566.87 -22.21 -58.56 220.96 112.49 58.67 1.95 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 0.30% -0.08% -43.98% -1.54% -4.62% 13.67% 8.51% 4.17% 0.35% PAT Growth 100.68% - - - - 96.43% 91.73% 2,908.72% EPS 0.76 -0.22 -117.61 -4.61 -12.15 45.84 23.34 12.17 0.40

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Net Sales 1,206.01 1,283.76 1,288.92 1,443.81 1,268.35 1,616.88 1,321.75 1,408.58 560.41 Net Sales Growth -1.29% -0.40% -10.73% 13.83% -21.56% 22.33% -6.16% 151.35% Cost Of Goods Sold 553.42 626.41 805.02 788.83 653.89 724.42 598.87 724.03 293.38 Gross Profit 652.59 657.35 483.90 654.98 614.46 892.46 722.88 684.55 267.03 GP Margin 54.11% 51.21% 37.54% 45.36% 48.45% 55.20% 54.69% 48.60% 47.65% Total Expenditure 1,011.21 1,077.48 1,384.10 1,309.93 1,188.38 1,231.01 1,062.31 1,197.03 500.80 Power & Fuel Cost - 94.37 122.56 108.10 93.70 85.42 77.68 79.35 31.41 % Of Sales - 7.35% 9.51% 7.49% 7.39% 5.28% 5.88% 5.63% 5.60% Employee Cost - 211.69 243.92 228.63 236.34 229.37 204.13 187.82 71.51 % Of Sales - 16.49% 18.92% 15.84% 18.63% 14.19% 15.44% 13.33% 12.76% Manufacturing Exp. - 68.50 109.98 91.64 100.60 95.82 94.74 101.85 48.02 % Of Sales - 5.34% 8.53% 6.35% 7.93% 5.93% 7.17% 7.23% 8.57% General & Admin Exp. - 38.05 41.07 39.43 49.31 47.86 47.70 35.50 15.22 % Of Sales - 2.96% 3.19% 2.73% 3.89% 2.96% 3.61% 2.52% 2.72% Selling & Distn. Exp. - 24.31 34.18 31.68 30.28 31.88 24.70 31.33 17.84 % Of Sales - 1.89% 2.65% 2.19% 2.39% 1.97% 1.87% 2.22% 3.18% Miscellaneous Exp. - 14.15 27.37 21.62 24.26 16.24 14.49 37.15 23.42 % Of Sales - 1.10% 2.12% 1.50% 1.91% 1.00% 1.10% 2.64% 4.18% EBITDA 194.80 206.28 -95.18 133.88 79.97 385.87 259.44 211.55 59.61 EBITDA Margin 16.15% 16.07% -7.38% 9.27% 6.31% 23.87% 19.63% 15.02% 10.64% Other Income 8.91 8.32 5.37 22.55 20.02 28.77 27.52 12.38 2.47 Interest 100.39 114.81 105.11 90.06 75.28 84.48 77.89 82.48 25.17 Depreciation 96.91 99.25 103.33 111.19 112.32 108.66 94.16 83.70 36.71 PBT 6.41 0.54 -298.25 -44.82 -87.61 221.50 114.91 57.75 0.20 Tax 0.00 0.00 78.54 -22.57 -32.81 0.15 0.39 -1.66 -0.14 Tax Rate 0.00% 0.00% -16.08% 50.36% 36.02% 0.07% 0.34% -2.87% -70.00% PAT 6.41 0.54 -567.39 -22.18 -58.15 221.40 114.61 59.51 0.38 PAT before Minority Interest 6.41 0.54 -566.96 -22.25 -58.29 221.35 114.52 59.41 0.34 Minority Interest 0.00 0.00 -0.43 0.07 0.14 0.05 0.09 0.10 0.04 PAT Margin 0.53% 0.04% -44.02% -1.54% -4.58% 13.69% 8.67% 4.22% 0.07% PAT Growth 101.20% - - - - 93.18% 92.59% 15,560.53% EPS 1.33 0.11 -117.72 -4.60 -12.06 45.93 23.78 12.35 0.08

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Shareholder's Funds 1,096.21 937.42 1,503.13 1,527.05 1,592.79 1,090.79 962.45 769.87 Share Capital 40.25 36.00 36.00 36.00 35.93 26.85 25.77 24.67 Total Reserves 1,052.67 899.77 1,466.08 1,490.05 1,553.07 963.21 830.29 745.19 Non-Current Liabilities 190.82 171.53 217.16 299.22 206.53 333.09 344.00 314.88 Secured Loans 113.86 105.83 235.10 283.04 154.83 232.71 224.97 242.86 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 58.77 53.67 49.03 37.07 36.56 32.62 28.79 23.58 Current Liabilities 938.07 1,237.65 1,096.12 1,056.03 785.30 727.73 650.33 732.42 Trade Payables 242.59 307.70 300.69 268.54 305.62 215.72 242.52 312.59 Other Current Liabilities 120.35 167.71 144.55 174.15 116.97 156.36 190.99 88.35 Short Term Borrowings 572.90 760.27 648.80 609.90 360.88 353.79 214.46 330.21 Short Term Provisions 2.23 1.97 2.08 3.44 1.83 1.86 2.36 1.27 Total Liabilities 2,225.10 2,346.60 2,816.41 2,882.30 2,584.62 2,151.61 1,956.78 1,817.17 Net Block 1,184.52 1,258.70 1,333.22 1,325.00 1,359.01 1,374.09 1,194.74 1,062.54 Gross Block 1,889.24 1,869.35 1,860.64 1,753.44 1,678.31 1,587.46 1,315.86 1,099.10 Accumulated Depreciation 704.72 610.65 527.42 428.44 319.30 213.37 121.12 36.56 Non Current Assets 1,496.50 1,555.95 1,625.54 1,642.43 1,526.63 1,476.26 1,307.12 1,208.63 Capital Work in Progress 280.05 256.37 238.47 238.65 87.72 40.21 39.20 70.31 Non Current Investment 1.70 14.25 16.05 14.77 18.13 18.03 18.12 18.53 Long Term Loans & Adv. 27.52 23.76 28.50 54.38 60.60 39.55 35.63 48.23 Other Non Current Assets 0.43 0.48 0.51 0.48 1.17 4.38 19.43 9.03 Current Assets 728.60 790.65 1,190.87 1,239.87 1,057.99 675.35 649.66 608.53 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 317.90 359.70 558.09 575.55 294.97 279.73 213.94 187.66 Sundry Debtors 326.57 351.22 539.65 489.67 483.81 229.67 290.24 263.35 Cash & Bank 3.97 8.48 8.71 47.14 198.38 56.58 76.37 46.93 Other Current Assets 80.16 18.84 24.08 18.67 80.83 109.37 69.11 110.59 Short Term Loans & Adv. 51.57 52.41 60.34 108.84 7.32 19.07 19.59 35.10 Net Current Assets -209.47 -447.00 94.75 183.84 272.69 -52.38 -0.67 -123.89 Total Assets 2,225.10 2,346.60 2,816.41 2,882.30 2,584.62 2,151.61 1,956.78 1,817.16

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Shareholder's Funds 1,094.24 933.91 1,500.21 1,524.87 1,588.53 1,085.94 955.87 763.98 Share Capital 40.25 36.00 36.00 36.00 35.93 26.85 25.77 24.67 Total Reserves 1,050.70 896.26 1,463.16 1,487.87 1,548.81 958.36 823.71 739.30 Non-Current Liabilities 190.82 171.53 217.14 299.22 206.46 333.31 344.23 315.06 Secured Loans 113.86 105.83 235.10 283.04 154.83 232.71 224.97 242.86 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 58.77 53.67 49.03 37.07 36.56 32.62 28.79 23.58 Current Liabilities 944.11 1,242.79 1,101.13 1,063.42 788.74 729.89 655.50 737.95 Trade Payables 248.62 313.01 305.86 275.99 309.29 216.12 244.38 312.87 Other Current Liabilities 120.35 167.53 144.38 173.76 116.60 157.28 192.24 90.08 Short Term Borrowings 572.90 760.27 648.80 609.90 360.88 353.79 214.47 330.21 Short Term Provisions 2.24 1.98 2.09 3.77 1.97 2.70 4.41 4.78 Total Liabilities 2,231.84 2,350.90 2,820.72 2,889.82 2,587.97 2,153.43 1,959.98 1,821.47 Net Block 1,191.12 1,265.50 1,340.02 1,331.80 1,381.58 1,396.94 1,217.80 1,085.93 Gross Block 1,896.05 1,876.36 1,867.65 1,760.45 1,702.15 1,611.23 1,339.37 1,122.64 Accumulated Depreciation 704.93 610.86 527.63 428.65 320.57 214.29 121.57 36.71 Non Current Assets 1,503.11 1,550.21 1,633.18 1,650.54 1,530.34 1,481.44 1,311.88 1,213.66 Capital Work in Progress 280.05 256.37 238.47 238.65 87.98 40.47 40.37 71.48 Non Current Investment 1.70 1.70 1.70 0.42 0.42 0.32 0.41 0.81 Long Term Loans & Adv. 27.53 23.77 28.54 54.60 59.19 40.83 36.23 46.40 Other Non Current Assets 0.43 0.48 0.51 0.48 1.17 2.88 17.07 9.03 Current Assets 728.73 788.07 1,187.54 1,239.28 1,057.63 671.99 648.10 607.81 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 317.90 359.70 558.09 575.55 294.97 279.73 213.94 187.66 Sundry Debtors 326.57 348.52 536.99 489.67 483.87 226.53 288.80 262.52 Cash & Bank 4.11 8.60 8.89 47.25 198.54 56.78 76.47 47.01 Other Current Assets 80.15 18.84 23.22 17.94 80.25 108.95 68.89 110.62 Short Term Loans & Adv. 51.56 52.41 60.35 108.87 7.32 69.08 19.76 35.14 Net Current Assets -215.38 -454.72 86.41 175.86 268.89 -57.90 -7.40 -130.14 Total Assets 2,231.84 2,338.28 2,820.72 2,889.82 2,587.97 2,153.43 1,959.98 1,821.47

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Cash From Operating Activity 212.80 110.95 156.17 -241.77 154.44 242.02 165.72 49.63 PBT -1.08 -488.33 -44.78 -91.66 220.96 112.49 58.44 1.95 Adjustment 212.16 405.79 186.88 181.98 173.16 167.54 148.31 62.33 Changes in Working Capital 2.62 192.57 0.36 -314.04 -207.11 -14.50 -26.51 -11.67 Cash after chg. in Working capital 213.70 110.03 142.46 -223.72 187.01 265.53 180.24 52.61 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.90 0.92 13.71 -18.05 -32.57 -23.51 -14.52 -2.98 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -36.83 -4.66 -81.13 -243.08 -105.25 -358.81 -115.64 -85.49 Net Fixed Assets -43.57 -26.61 -107.02 -226.06 -138.36 -272.61 -185.65 Net Investments 12.55 1.80 -1.28 3.36 -0.10 0.09 0.41 Others -5.81 20.15 27.17 -20.38 33.21 -86.29 69.60 Cash from Financing Activity -180.48 -106.52 -112.76 333.59 92.50 97.01 -23.00 67.36 Net Cash Inflow / Outflow -4.51 -0.23 -37.72 -151.26 141.69 -19.78 27.08 31.50 Opening Cash & Equivalents 8.32 8.55 46.27 197.53 55.84 75.62 45.87 0.00 Closing Cash & Equivalent 3.81 8.32 8.55 46.27 197.53 55.84 75.62 45.87

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Cash From Operating Activity 212.82 108.87 156.25 -242.03 155.46 242.15 166.33 49.22 PBT 0.54 -488.42 -44.82 -91.10 221.50 114.91 57.75 0.20 Adjustment 210.16 405.76 186.79 180.96 173.16 168.03 148.26 62.76 Changes in Working Capital 3.02 190.63 0.74 -313.79 -205.84 -16.45 -25.29 -10.84 Cash after chg. in Working capital 213.72 107.97 142.71 -223.93 188.82 266.49 180.72 52.11 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.90 0.90 13.54 -18.10 -33.36 -24.34 -14.39 -2.89 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -36.83 -3.51 -81.14 -242.85 -106.30 -358.81 -115.69 -85.47 Net Fixed Assets -43.57 -26.61 -107.02 -226.06 -138.36 -272.61 -185.65 Net Investments 12.55 1.80 -1.28 3.36 -0.10 0.09 0.41 Others -5.81 21.30 27.16 -20.15 32.16 -86.29 69.55 Cash from Financing Activity -180.48 -105.65 -112.76 333.57 92.49 96.98 -23.39 67.74 Net Cash Inflow / Outflow -4.49 -0.29 -37.65 -151.31 141.65 -19.68 27.25 31.49 Opening Cash & Equivalents 8.44 8.73 46.38 197.69 56.04 75.72 45.95 0.00 Closing Cash & Equivalent 3.95 8.44 8.73 46.38 197.69 56.04 75.72 45.95

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Book Value (Rs.) 271.53 239.57 384.55 423.90 442.25 368.74 332.19 312.02 ROA -0.05% -21.96% -0.78% -2.14% 9.33% 5.48% 3.11% 0.11% ROE -0.11% -46.51% -1.47% -3.76% 17.13% 12.19% 7.22% 0.25% ROCE 5.97% -17.22% 1.79% -0.69% 15.28% 11.54% 9.71% 1.93% Fixed Asset Turnover 0.68 0.69 0.80 0.74 0.99 0.91 1.17 0.51 Receivable days 96.36 126.14 130.11 140.07 80.53 71.79 71.72 171.52 Inventory Days 96.33 129.95 143.29 125.26 64.87 68.16 52.03 122.23 Payable days 160.32 137.92 131.69 160.25 131.34 75.41 84.29 228.78 Cash Conversion Cycle 32.36 118.17 141.71 105.08 14.06 64.54 39.47 64.97 Total Debt/Equity 0.71 1.07 0.67 0.67 0.38 0.71 0.63 0.82 Interest Cover 0.99 -3.61 0.50 -0.22 3.62 2.44 1.71 1.08

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Book Value (Rs.) 271.04 238.67 383.80 423.30 441.06 366.93 329.64 309.63 ROA 0.02% -21.93% -0.78% -2.13% 9.34% 5.57% 3.14% 0.02% ROE 0.05% -46.64% -1.47% -3.75% 17.23% 12.48% 7.36% 0.04% ROCE 6.07% -17.29% 1.79% -0.67% 15.34% 11.73% 9.70% 1.82% Fixed Asset Turnover 0.68 0.69 0.80 0.73 0.98 0.90 1.14 0.50 Receivable days 95.97 125.38 129.77 140.08 80.18 71.15 71.43 170.98 Inventory Days 96.33 129.95 143.29 125.26 64.87 68.16 52.03 122.23 Payable days 163.63 140.30 134.61 163.35 132.36 75.74 84.47 228.45 Cash Conversion Cycle 28.67 115.03 138.45 101.99 12.69 63.58 39.00 64.76 Total Debt/Equity 0.71 1.07 0.67 0.67 0.38 0.72 0.63 0.83 Interest Cover 1.00 -3.65 0.50 -0.21 3.62 2.48 1.70 1.01

Top Investors:

authum investment and infrastructure limited

spiracca ventures llp .

tpg growth iv sf pte. ltd.

the scottish oriental smaller companies trustplc

hbm healthcare investments (cayman) ltd

fssa indian subcontinent fund as sub fund of first sentier investors global umbrella fund plc

caisse de depot et placement du quebec

route one offshore master fund, l.p.

raptakos, brett and co. ltd.

Annual Reports:

News Update:

USFDA completes inspection at Solara Active Pharma Sciences’ Mangalore facility
19th Nov 2025, 12:50 PM

The Agency has issued an EIR on November 18, 2025 and determined that the inspection classification of the facility is VAI and concluded this inspection as closed
Read More
Solara Active Pharma - Quarterly Results
6th Nov 2025, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback